MXL 最新10-Q变化
将 MXL 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-07-23 与上一份 10-Q · 2026-04-23
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +29 | −22 | ~20 | 25 |
| 市场风险(第3项) | 文字有新增/删除 | 0 | 0 | ~2 | 1 |
| 控制与程序 | 文字有新增/删除 | +1 | 0 | ~1 | 2 |
| 风险因素 | 公司称无重大变化(指向 10-K) | — | — | — | — |
| 其他信息 | 无段落级文字变化 | 0 | 0 | 0 | 2 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):法律诉讼
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-07-23
Net revenue increased $101.3 million to $306.0 million for the six months ended June 30, 2026, as compared to $204.7 million for the six months ended June 30, 2025, driven by increased demand in our infrastructure and industrial and multi-market categories. The increase in infrastructure net revenue…
Cost of net revenue increased $40.1 million to $129.5 million for the six months ended June 30, 2026, as compared to $89.4 million for the six months ended June 30, 2025. The increase was driven by an increase in the volume of sales as described above under “Net Revenue”. Gross profit percentage imp…
Research and development expense increased $8.8 million to $56.0 million for the three months ended June 30, 2026, as compared to $47.2 million for the three months ended June 30, 2025. The increase was driven by increases in stock-based compensation of $2.9 million, bonus expense of $2.5 million, p…
Research and development expense increased $6.5 million to $109.2 million for the six months ended June 30, 2026, as compared to $102.7 million for the six months ended June 30, 2025. The increase was driven by increases in bonus expense of $4.4 million, and the impact of a decrease in income from j…
expense is due to improved financial performance over the prior period. The decrease in stock-based compensation related to timing of expense pertaining to equity retention grants made to employees in late 2024. The amount of income from research and development funded by others varies from period t…
相对上期删除的文字 · 来源:10-Q · 2026-04-23
Research and development expense decreased $2.3 million to $53.2 million for the three months ended March 31, 2026, as compared to $55.5 million for the three months ended March 31, 2025. The decrease was driven by decreases in stock-based compensation of $5.0 million, prototype expenses of $1.0 mil…
We have reduced our research and development spending to align with current project demands and expect our research and development expenses to increase in future years as we develop products to drive future growth.
Selling, general and administrative expense increased $5.9 million to $42.5 million for the three months ended March 31, 2026, as compared to $36.6 million for the three months ended March 31, 2025. The increase was driven by increases in stock-based compensation of $2.2 million, professional fees o…
Our selling, general and administrative expenses have increased over the prior year due to the factors described above. We expect selling, general and administrative expenses to increase in future years when we return to growing our sales and marketing organization to expand into existing and new ma…
Restructuring charges decreased $7.4 million to $0.5 million for the three months ended March 31, 2026, compared to $7.9 million for the three months ended March 31, 2025. Restructuring charges for the three months ended March 31, 2026 included $0.4 million in lease related charges. Restructuring ch…
控制与程序
相对上期新增的文字 · 来源:10-Q · 2026-07-23
identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 of the Securities Exchange Act of 1934, as amended, that occurred during the fiscal quarter ended June 30, 2026 that materially affected, or is reasonably likely to materially affect, our internal co…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议